Novel regulatory elements

Details for Australian Patent Application No. 2009273239 (hide)

Owner Boehringer Ingelheim Pharma GmbH & Co. KG

Inventors Enenkel, Barbara

Agent Spruson & Ferguson

Pub. Number AU-A-2009273239

PCT Pub. Number WO2010/010107

Priority 08161029.7 23.07.08 EP

Filing date 22 July 2009

Wipo publication date 28 January 2010

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

C12N 15/67 (2006.01) Mutation or genetic engineering - General methods for enhancing the expression

Event Publications

11 November 2010 PCT application entered the National Phase

  PCT publication WO2010/010107 Priority application(s): WO2010/010107

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009273247-Rinsing method for a water-bearing domestic appliance, especially dishwasher

2009273238-Aminophosphinic derivatives that can be used in the treatment of pain